Drug interactions between daclizumab and mycophenolate mofetil
Interactions between your drugs
There were no interactions found in our database between daclizumab and mycophenolate mofetil - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Daclizumab is in the drug class interleukin inhibitors.
- Daclizumab is used to treat the following conditions:
- Mycophenolate mofetil is a member of the drug class selective immunosuppressants.
- Mycophenolate mofetil is used to treat the following conditions:
- Autoimmune Hepatitis
- Bullous Pemphigoid
- Cogan's Syndrome
- Crohn's Disease
- Evan's Syndrome
- Graft-versus-host disease
- High Cholesterol
- Inflammatory Bowel Disease
- Linear IgA Disease
- Multiple Sclerosis
- Myasthenia Gravis
- Nephrotic Syndrome
- Organ Transplant, Rejection Prophylaxis
- Psoriatic Arthritis
- Pulmonary Fibrosis
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Ulcerative Colitis
Drug and food interactions
No results found in our database - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.